Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2026)

Inspire Medical Systems (INSP) has 8 years of Long-Term Investments data on file, last reported at $115.9 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 158.49% year-over-year to $115.9 million; the trailing twelve-month figure through Mar 2026 stood at $115.9 million (up 158.49% YoY), and the FY2025 full-year result was $96.3 million, up 35.69% from the prior year.
• Long-Term Investments advanced to $115.9 million in Q1 2026, from $96.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $115.9 million in Q1 2026 to a low of $3.0 million in Q3 2023.
• A 5-year average of $59.6 million and a median of $57.9 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments surged 4701.96% in 2022 and slipped 22.1% in 2025, its largest moves.
• Tracing INSP's Long-Term Investments over 5 years: stood at $9.8 million in 2022, then decreased by 6.67% to $9.1 million in 2023, then jumped by 676.5% to $71.0 million in 2024, then jumped by 35.69% to $96.3 million in 2025, then gained by 20.3% to $115.9 million in 2026.
• Business Quant data shows INSP's Long-Term Investments at $115.9 million in Q1 2026, $96.3 million in Q4 2025, and $88.4 million in Q3 2025.